![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 27435 |
FusionGeneSummary for PLA2G2A_FBLN1 |
![]() |
Fusion gene information | Fusion gene name: PLA2G2A_FBLN1 | Fusion gene ID: 27435 | Hgene | Tgene | Gene symbol | PLA2G2A | FBLN1 | Gene ID | 5320 | 2192 |
Gene name | phospholipase A2 group IIA | fibulin 1 | |
Synonyms | MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2 | FBLN|FIBL1 | |
Cytomap | 1p36.13 | 22q13.31 | |
Type of gene | protein-coding | protein-coding | |
Description | phospholipase A2, membrane associatedGIIC sPLA2NPS-PLA2group IIA phospholipase A2non-pancreatic secretory phospholipase A2phosphatidylcholine 2-acylhydrolase 2Aphospholipase A2, group IIA (platelets, synovial fluid) | fibulin-1 | |
Modification date | 20180519 | 20180522 | |
UniProtAcc | P14555 | P23142 | |
Ensembl transtripts involved in fusion gene | ENST00000400520, ENST00000496748, ENST00000375111, | ENST00000348697, ENST00000402984, ENST00000262722, ENST00000327858, ENST00000442170, ENST00000340923, ENST00000476366, | |
Fusion gene scores | * DoF score | 6 X 2 X 1=12 | 12 X 11 X 7=924 |
# samples | 6 | 13 | |
** MAII score | log2(6/12*10)=2.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(13/924*10)=-2.8293812283876 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PLA2G2A [Title/Abstract] AND FBLN1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PLA2G2A | GO:0006644 | phospholipid metabolic process | 17069818 |
Hgene | PLA2G2A | GO:0046473 | phosphatidic acid metabolic process | 9032461 |
Hgene | PLA2G2A | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 22837859 |
Tgene | FBLN1 | GO:0001933 | negative regulation of protein phosphorylation | 11792823 |
Tgene | FBLN1 | GO:0007162 | negative regulation of cell adhesion | 11792823 |
Tgene | FBLN1 | GO:0007229 | integrin-mediated signaling pathway | 11792823 |
Tgene | FBLN1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 11792823 |
Tgene | FBLN1 | GO:0072378 | blood coagulation, fibrin clot formation | 7642629 |
Tgene | FBLN1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading | 11792823 |
Tgene | FBLN1 | GO:2000146 | negative regulation of cell motility | 11792823 |
Tgene | FBLN1 | GO:2000647 | negative regulation of stem cell proliferation | 11238726 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | PRAD | TCGA-KK-A7AQ-01A | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000400520 | ENST00000348697 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
intron-intron | ENST00000400520 | ENST00000402984 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
intron-intron | ENST00000400520 | ENST00000262722 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
intron-intron | ENST00000400520 | ENST00000327858 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
intron-intron | ENST00000400520 | ENST00000442170 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
intron-intron | ENST00000400520 | ENST00000340923 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
intron-intron | ENST00000400520 | ENST00000476366 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000496748 | ENST00000348697 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000496748 | ENST00000402984 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000496748 | ENST00000262722 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000496748 | ENST00000327858 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000496748 | ENST00000442170 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000496748 | ENST00000340923 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000496748 | ENST00000476366 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000375111 | ENST00000348697 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000375111 | ENST00000402984 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000375111 | ENST00000262722 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000375111 | ENST00000327858 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000375111 | ENST00000442170 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000375111 | ENST00000340923 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
5CDS-intron | ENST00000375111 | ENST00000476366 | PLA2G2A | chr1 | 20301931 | - | FBLN1 | chr22 | 45914462 | + |
Top |
FusionProtFeatures for PLA2G2A_FBLN1 |
![]() |
Hgene | Tgene |
PLA2G2A | FBLN1 |
Catalyzes the calcium-dependent hydrolysis of the 2-acylgroups in 3-sn-phosphoglycerides (PubMed:2925633). Thought toparticipate in the regulation of phospholipid metabolism inbiomembranes including eicosanoid biosynthesis. Independent of itscatalytic activity, acts as a ligand for integrins(PubMed:18635536, PubMed:25398877). Binds to and activatesintegrins ITGAV:ITGB3, ITGA4:ITGB1 and ITGA5:ITGB1(PubMed:18635536, PubMed:25398877). Binds to a site (site 2) whichis distinct from the classical ligand-binding site (site 1) andinduces integrin conformational changes and enhanced ligandbinding to site 1 (PubMed:25398877). Induces cell proliferation inan integrin-dependent manner (PubMed:18635536).{ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:25398877,ECO:0000269|PubMed:2925633}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PLA2G2A_FBLN1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PLA2G2A_FBLN1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
PLA2G2A | PLA2G1B, DCN, CEP70, BAG6, PLA2G2A, VIM, UCHL5, UCHL3, USP8, USP7, USP5, USP47, USP4, USP28, USP20, USP2, USP15, UCHL1, SENP6, JOSD2, SENP8, KRAS, ALOX12, ITGAV, ITGB3, TGM2 | FBLN1 | MPG, APP, NID1, ELN, FBLN1, FGB, FN1, NOV, CTGF, CACNA1A, ATN1, GFI1B, SKIL, SMAD4, TCF7L2, ADAMTSL4, TAF9, SMAD3, NOTCH3, PLSCR1, TDGF1, LTBP4, TANK, YWHAQ, NEDD1, APOA1, BHLHE40, ADAMTSL2, EDC4, DKK1, LGALS9, FCN1, PLSCR4, SFRP4, KCTD9, PTPRK, PSG1, PSG3, WNT4, ZFP41, IFI30, NLGN3, DDIAS, OCLN, DEFA1, COLQ, WNT7A, IRF9, PAK7, EFEMP1, ZNF517, NELL1, FAM19A3, PLA2G10, CCDC89, TYW3, AGRP, TRIM25, MCPH1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PLA2G2A_FBLN1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | PLA2G2A | P14555 | DB00328 | Indomethacin | Phospholipase A2, membrane associated | small molecule | approved|investigational |
Hgene | PLA2G2A | P14555 | DB02325 | Isopropyl Alcohol | Phospholipase A2, membrane associated | small molecule | approved|investigational |
Hgene | PLA2G2A | P14555 | DB04786 | Suramin | Phospholipase A2, membrane associated | small molecule | approved|investigational |
Hgene | PLA2G2A | P14555 | DB01381 | Ginkgo biloba | Phospholipase A2, membrane associated | small molecule | approved|investigational|nutraceutical |
Hgene | PLA2G2A | P14555 | DB00586 | Diclofenac | Phospholipase A2, membrane associated | small molecule | approved|vet_approved |
Top |
RelatedDiseases for PLA2G2A_FBLN1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PLA2G2A | C0005586 | Bipolar Disorder | 2 | PSYGENET |
Hgene | PLA2G2A | C0004153 | Atherosclerosis | 1 | CTD_human |
Hgene | PLA2G2A | C0011581 | Depressive disorder | 1 | PSYGENET |
Hgene | PLA2G2A | C0014175 | Endometriosis | 1 | CTD_human |
Hgene | PLA2G2A | C0035126 | Reperfusion Injury | 1 | CTD_human |
Hgene | PLA2G2A | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | PLA2G2A | C0349218 | Recurrent depressive disorder, unspecified | 1 | PSYGENET |
Hgene | PLA2G2A | C1839839 | MAJOR AFFECTIVE DISORDER 2 | 1 | PSYGENET |
Tgene | FBLN1 | C0014175 | Endometriosis | 1 | CTD_human |
Tgene | FBLN1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |